APA (7th ed.) Citation

Pertsinidou, E., Saevarsdottir, S., Manivel, V. A., Klareskog, L., Alfredsson, L., Mathsson-Alm, L., . . . Rönnelid, J. (2024). In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the rheumatic diseases, 83(3), 277-287. https://doi.org/10.1136/ard-2023-224728

Chicago Style (17th ed.) Citation

Pertsinidou, Eleftheria, et al. "In Early Rheumatoid Arthritis, Anticitrullinated Peptide Antibodies Associate with Low Number of Affected Joints and Rheumatoid Factor Associates with Systemic Inflammation." Annals of the Rheumatic Diseases 83, no. 3 (2024): 277-287. https://doi.org/10.1136/ard-2023-224728.

MLA (9th ed.) Citation

Pertsinidou, Eleftheria, et al. "In Early Rheumatoid Arthritis, Anticitrullinated Peptide Antibodies Associate with Low Number of Affected Joints and Rheumatoid Factor Associates with Systemic Inflammation." Annals of the Rheumatic Diseases, vol. 83, no. 3, 2024, pp. 277-287, https://doi.org/10.1136/ard-2023-224728.